Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Journal of Structural Biology
|
July 7, 2009
Internodal myelination during development quantitated using X-ray diffraction
Deepika Agrawal, Rachel Hawk, Robin L Avila, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 12, 2024
Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFFIRM trial
Kunio Nakamura, Zhaonan Sun, Claire Hara-Cleaver, et al.
Neurochemical Research
|
September 5, 2006
Myelin structure and composition in zebrafish
Robin L Avila, Brian R Tevlin, Jonathan P B Lees, et al.
Biophysical Journal
|
December 5, 2006
Cytoplasmic domain of human myelin protein zero likely folded as beta-structure in compact myelin
Xiaoyang Luo, Deepak Sharma, Hideyo Inouye, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 26, 2024
The impact of social distancing measures on anti-JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis
Stephen C Krieger, Susie Sinks, Furong Huang, et al.
The Journal of Biological Chemistry
|
October 13, 2010
P0 (protein zero) mutation S34C underlies instability of internodal myelin in S63C mice
Robin L Avila, Maurizio D'Antonio, Angela Bachi, et al.
Therapeutic Advances in Neurological Disorders
|
March 18, 2025
Evaluating natalizumab first-line and later-line use in multiple sclerosis: a US claims database analysis
Robin L Avila, Nicole S Croteau, Fei Tang, et al.
Journal of Negative Results in Biomedicine
|
July 12, 2007
Peripheral nervous system manifestations in a Sandhoff disease mouse model: nerve conduction, myelin structure, lipid analysis
Melanie A McNally, Rena C Baek, Robin L Avila, et al.
Neurodegenerative Disease Management
|
April 16, 2024
Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab
Carrie M Hersh, Menglan Pang, Deborah M Miller, et al.
Brain : a Journal of Neurology
|
September 21, 2010
A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination
Maria Traka, Kavin Arasi, Robin L Avila, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Journal of Structural Biology
|
July 7, 2009
Internodal myelination during development quantitated using X-ray diffraction
Deepika Agrawal, Rachel Hawk, Robin L Avila, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 12, 2024
Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFFIRM trial
Kunio Nakamura, Zhaonan Sun, Claire Hara-Cleaver, et al.
Neurochemical Research
|
September 5, 2006
Myelin structure and composition in zebrafish
Robin L Avila, Brian R Tevlin, Jonathan P B Lees, et al.
Biophysical Journal
|
December 5, 2006
Cytoplasmic domain of human myelin protein zero likely folded as beta-structure in compact myelin
Xiaoyang Luo, Deepak Sharma, Hideyo Inouye, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 26, 2024
The impact of social distancing measures on anti-JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis
Stephen C Krieger, Susie Sinks, Furong Huang, et al.
The Journal of Biological Chemistry
|
October 13, 2010
P0 (protein zero) mutation S34C underlies instability of internodal myelin in S63C mice
Robin L Avila, Maurizio D'Antonio, Angela Bachi, et al.
Therapeutic Advances in Neurological Disorders
|
March 18, 2025
Evaluating natalizumab first-line and later-line use in multiple sclerosis: a US claims database analysis
Robin L Avila, Nicole S Croteau, Fei Tang, et al.
Journal of Negative Results in Biomedicine
|
July 12, 2007
Peripheral nervous system manifestations in a Sandhoff disease mouse model: nerve conduction, myelin structure, lipid analysis
Melanie A McNally, Rena C Baek, Robin L Avila, et al.
Neurodegenerative Disease Management
|
April 16, 2024
Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab
Carrie M Hersh, Menglan Pang, Deborah M Miller, et al.
Brain : a Journal of Neurology
|
September 21, 2010
A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination
Maria Traka, Kavin Arasi, Robin L Avila, et al.
Page
of 4